Journal profile · Psychiatry
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
ISSN 1461-1457 · eISSN 1469-5111 · Oxford University Press · ENGLAND · Bimonthly · Founded 1998
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY: CAS Zone 2 · Medicine (2025 upgraded edition); impact factor 4.77; fully open access; APC charged, amount not published; median 134 days to acceptance (95 articles, last 24 months); community-reported acceptance: fairly hard; 1,150 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY is published by Oxford University Press and is in Zone 2 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Neurotransmitter Receptor Influence on Behavior, Tryptophan and brain disorders and Treatment of Major Depression, together about 31.6% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
The central focus of the journal is on research that advances understanding of existing and new neuropsychopharmacological agents including their mode of action and clinical application or provides insights into the biological basis of psychiatric disorders and thereby advances their pharmacological treatment. Such research may derive from the full spectrum of biological and psychological fields of inquiry encompassing classical and novel techniques in neuropsychopharmacology as well as strategies such as neuroimaging, genetics, psychoneuroendocrinology and neuropsychology. Emphasis is given to original research (in the form of full-length papers and brief reports), which is of wide interest and clearly advances the field. Selected review articles and papers that highlight novel trends and perspectives are also considered. Journal metrics Citation metrics Clarivate 2025 Impact Factor 4.8 2025 5 Year Impact Factor 5.3 Clinical Neurology (Rank by Impact Factor) 42/296 Psychiatry (Rank by Impact Factor) 47/293 Pharmacology & Pharmacy (Rank by Impact Factor) 77/356 Neurosciences (Rank by Impact Factor) 73/330 2025 Cited Half-Life 9.5 years 2025 Immediacy Index 1.9 2025 Eigenfactor Score 0.00434 2025 Article Influence Score 1.495 Scopus 2025 CiteScore 8.3 Psychiatry And Mental Health (Rank by CiteScore) 58/580 Pharmacology (Medical) (Rank by CiteScore) 38/278 Pharmacology (Rank by CiteScore) 60/328 2025 Source Normalized Impact per Paper (SNIP) 1.401 Readership 2025 Full Text Usage 934,248 Peer Review and Production 2025 Median days from submission to first decision 22.5 days 2025 Median days from submission to final decision 29.5 days 2025 Median days from acceptance to publication 9 days About metrics IJNP by the Numbers Ranked in the top 25% of journals in Psychiatry, Clinical Neurology, and Pharmacology Wide distribution of readers in Asia (14%), Europe (27%), and North America (42%) Average 9.1 days from receipt in production to online proof publication
From the journal's Aims & Scope
Research area (LetPub): Psychiatry
Editor-in-chief Gregers WegenerPublisher website
Editorial board by country: 1 in mainland China (about 1%); most named United States 13, Japan 9, United Kingdom 7, Sweden 7, Italy 4 (76 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Neurotransmitter Receptor Influence on BehaviorNeuroscience12.7%
- Tryptophan and brain disordersNeuroscience9.4%
- Treatment of Major DepressionMedicine9.4%
- Schizophrenia research and treatmentMedicine7.4%
- Neuroscience and Neuropharmacology ResearchNeuroscience6.9%
- Stress Responses and CortisolNeuroscience6.4%
- Bipolar Disorder and TreatmentMedicine5.3%
- Receptor Mechanisms and SignalingBiochemistry, Genetics and Molecular Biology4%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Neurosciences | Zone 2 |
| Minor | Pharmacology & Pharmacy | Zone 2 |
| Minor | Psychiatry | Zone 2 |
| Minor | Clinical Neurology | Zone 3 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Clinical Neurology | Zone 3 |
| Minor | Neurosciences | Zone 3 |
| Minor | Pharmacology & Pharmacy | Zone 2 |
| Minor | Psychiatry | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Pharmacology & Pharmacy | Zone 2 |
| Minor | Clinical Neurology | Zone 3 |
| Minor | Neurosciences | Zone 3 |
| Minor | Psychiatry | Zone 3 |
Top journal: noReview journal: no
Database indexing
SCIEScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 4.77LetPub ·
- Impact factor (publisher) 2025
- 4.8Publisher website ·
- 5-year impact factor (publisher) 2025
- 5.3Publisher website ·
- CiteScore 2026-06
- 8.3LetPub ·
- CiteScore (publisher) 2025
- 8.3Publisher website ·
- SJR 2026-06
- 1.65LetPub ·
- SNIP 2026-06
- 1.4LetPub ·
- h-index
- 93LetPub ·
- h-index
- 156OpenAlex ·
- i10-index
- 2,321OpenAlex ·
- 2-year mean citedness
- 0.65OpenAlex ·
- Self-citation rate
- 2.1%LetPub ·
- Share of gold OA articles
- 100%LetPub ·
Volume
- Articles per year
- 75LetPub ·
- Downloads per year (publisher) 2025
- 934,248Publisher website ·
Articles by year OpenAlex count · 5,719 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 567 | 567 | 17 |
| 2025 | 1,150 | 1,150 | 547 |
| 2024 | 69 | 69 | 588 |
| 2023 | 68 | 68 | 829 |
| 2022 | 237 | 237 | 1,792 |
| 2021 | 94 | 94 | 2,240 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
134 daysMedian, submission to acceptance · P25–P75 96 days – 185 days
- Acceptance to online
- median 7 days (3 articles)
- Submission to online
- median 288 days
- Sample
- 95 articles with submission and acceptance dates (144 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- 4–8 weeksLetPub ·
- Average acceptance (community reports)
- Fairly hardLetPub ·
- Submission to first decision 2025
- 22.5 daysPublisher website ·
- Submission to final decision 2025
- 29.5 daysPublisher website ·
- Acceptance to publication
- 9 daysPublisher website ·
- Submission to publication (journal-reported)
- about 12 weeksDOAJ ·
- Peer review
- Single anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | GBP 1,945 | Yes | CC BY, CC BY-NC | |
| OpenAlex | GBP 2,042 | — | — | |
| LetPub | GBP 1,945 | Yes | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Profile
Publication details and official links
- Publisher
- Oxford University Press
- Country or region
- ENGLAND
- Language
- English
- Frequency
- Bimonthly
- Founded
- 1998
- ISSN
- 1461-1457
- Electronic ISSN
- 1469-5111
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗Publisher website
- Author guidelines ↗LetPub
- Aims & Scope ↗LetPub
- APC information ↗DOAJ
- Fee waivers ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗LetPub
- Editorial board ↗LetPub
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
What CAS zone is INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY in?
In the 2025 upgraded edition of the CAS Journal Ranking, INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY is in Zone 2 of Medicine, and in Zone 2 of the minor category Neurosciences / Pharmacology & Pharmacy / Psychiatry / Clinical Neurology. In the 2026 Xinrui edition it is in Zone 2 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY?
The latest impact factor listed by LetPub is 4.77; CiteScore 8.3, h-index 156.
How long does peer review take at INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY?
Based on the dates recorded on 95 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 134 days (interquartile range 96–185 days); authors report an average review time of 4–8 weeks; the community-reported acceptance is “Fairly hard”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Where are the editorial board members of INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY based?
Of the 76 board members whose country the journal's board page names, 1 (about 1%) are in mainland China; the countries named most often are United States (13), Japan (9) and United Kingdom (7). Counted from the institutions listed on the board page; for reference only.
Which databases index INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY?
According to LetPub and DOAJ records, INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY is indexed in SCIE, Scopus and DOAJ.
Is INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY open access, and what is the APC?
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY is a fully open-access journal. APC charged, amount not published.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex, DOAJ; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .